2023 updates on the closed or open after-source control for severe complicated intraabdominal sepsis (COOL) trial

Jinjian Huang¹, Jianan Ren¹, Jessica L McKee², Andrew W Kirkpatrick^3
1 Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province, China
² COOL Trial Global Management, Edmonton, Alberta, Canada
³ Departments of Surgery, Critical Care Medicine, and The Trauma Program, University of Calgary, Calgary, Alberta, Canada

Correspondence Address:
Andrew W Kirkpatrick
Department of Surgery, Critical Care Medicine, and The Trauma Program, University of Calgary, Calgary, Alberta
Canada
Jianan Ren
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province
China

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/wjsi.wjsi_1_23